£33k
vs Dec 2023Active13095005Private limited companyHemel Hempstead
VANTAGE PHARMACEUTICALS LTD
Significant control: Melissa Pricilla Raval (25–50%), Anne-Laure Marie Wagstaff (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Vantage Pharmaceuticals Ltd sell?
Registered activity: Manufacture of pharmaceutical preparations (SIC 21200). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
VANTAGE PHARMACEUTICALS LTD is an active private limited company (company number 13095005) incorporated on 22 December 2020, registered in Hemel Hempstead. Its registered activity is manufacture of pharmaceutical preparations (SIC 21200). Latest small accounts cover the period ending 31 December 2024, showing net assets of £33k and cash of £480k, with 3 employees on average. Net assets rose 109% on the prior period (−£360k).
Peer position · net assets
By net assets it sits in the upper half of 307 comparable companies in the UK (median £1,000, upper quartile £146k).
02
Ownership and control
- Melissa Pricilla Raval
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mrs Anne-Laure Marie Wagstaff
- owns 25–50% of shares
- holds 25–50% of voting rights
- Mr Robert Gaurav Singh Johal
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 22 December 20205 yrs ago
- Next accounts due
- 30 September 202623 days overdue
- Confirmation statement due
- 5 January 2027in 74 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 21200
- Manufacture of pharmaceutical preparations
- SIC 86900
- Other human health activities
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£480k
+8799%vs Dec 2023Not reported
3
No changevs Dec 2023| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 December 2024 | £33k | £480k | £206k | £680k | — | — | 3 |
| 31 December 2023 | −£360k | £5,390 | £288k | £679k | — | — | 3 |
Current ratio1.05Current assets ÷ creditors within one year
Cash per employee£160kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £33,441 at 31 December 2024
- Net assets up 10% or more on the prior period+109.3% vs prior period
- Cash at bank of £50,000 or moreCash £479,639
- Incorporated five or more years agoIncorporated 22 December 2020
- Accounts past their due dateDue 30 September 2026
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Confirmation statement duein 74 days
- Next accounts due23 days overdue
- Accounts period endNet assets £33k · small accounts
- Accounts period endNet liabilities £360k · small accounts
- Incorporated
08
Similar companies in the UK
- CY BIOPHARMA LTDCheltenham · inc. Mar 2021
- BARBARA MAWER ENTERPRISES LIMITEDPenzance · inc. Apr 2021
- NEURONE LIMITEDCalne · inc. Jun 2021
- COVGUARD LIMITEDCheltenham · inc. Jun 2021
- CEUTICA LIMITEDSwindon · inc. Jul 2021
- BIOSIRIUS LTDPoole · inc. Aug 2021
All companies incorporated on 22 December 2020 · in Dec 2020.
09
Reminders for VANTAGE PHARMACEUTICALS LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.